Desq Long
Sign in

Company

Grace Therapeutics, Inc.

GRCE · CIK 0001444192

SEC FORM 4
$8,001.28

Grace Therapeutics, Inc. (GRCE)

Purchase of 4,256 shares at $1.88 per share.

Reporting Person Opaleye Management Inc. · Transaction Code P

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001493152-26-047949 · filed 2026-10-21 · View filing →

SEC FORM 4
$68,757.62

Grace Therapeutics, Inc. (GRCE)

Purchase of 36,347 shares at $1.8917 per share.

Reporting Person Opaleye Management Inc. · Transaction Code P

Traded Oct 16, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001493152-26-047473 · filed 2026-10-16 · View filing →

SEC FORM 4
$45,685.37

Grace Therapeutics, Inc. (GRCE)

Purchase of 23,485 shares at $1.9453 per share.

Reporting Person Opaleye Management Inc. · Transaction Code P

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001493152-26-047473 · filed 2026-10-16 · View filing →

SEC FORM 4
$21,734.73

Grace Therapeutics, Inc. (GRCE)

Purchase of 11,233 shares at $1.9349 per share.

Reporting Person Opaleye Management Inc. · Transaction Code P

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001493152-26-047473 · filed 2026-10-16 · View filing →

SEC FORM 4
$14,574.30

Grace Therapeutics, Inc. (GRCE)

Purchase of 7,215 shares at $2.02 per share.

Reporting Person Opaleye Management Inc. · Transaction Code P

Traded Oct 12, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001493152-26-046899 · filed 2026-10-13 · View filing →

SEC FORM 4
$10,918.16

Grace Therapeutics, Inc. (GRCE)

Purchase of 5,340 shares at $2.0446 per share.

Reporting Person Opaleye Management Inc. · Transaction Code P

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001493152-26-046899 · filed 2026-10-13 · View filing →

SEC FORM 4
$4,190.35

Grace Therapeutics, Inc. (GRCE)

Purchase of 2,077 shares at $2.0175 per share.

Reporting Person Opaleye Management Inc. · Transaction Code P

Traded Oct 8, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001493152-26-046899 · filed 2026-10-13 · View filing →

SEC FORM 4
$3,489.64

Grace Therapeutics, Inc. (GRCE)

Purchase of 1,694 shares at $2.06 per share.

Reporting Person Opaleye Management Inc. · Transaction Code P

Traded Oct 5, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001493152-26-045809 · filed 2026-10-05 · View filing →

SEC FORM 4
$41,368.00

Grace Therapeutics, Inc. (GRCE)

Purchase of 20,000 shares at $2.0684 per share.

Reporting Person Opaleye Management Inc. · Transaction Code P

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001493152-26-045809 · filed 2026-10-05 · View filing →

SEC FORM 4
$78,961.50

Grace Therapeutics, Inc. (GRCE)

Purchase of 38,796 shares at $2.0353 per share.

Reporting Person Opaleye Management Inc. · Transaction Code P

Traded Oct 1, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001493152-26-045809 · filed 2026-10-05 · View filing →

SEC FORM 4
$16,404.41

Grace Therapeutics, Inc. (GRCE)

Purchase of 7,849 shares at $2.09 per share.

Reporting Person Opaleye Management Inc. · Transaction Code P

Traded Sep 29, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001493152-26-045358 · filed 2026-10-01 · View filing →

SEC FORM 4
$11,167.80

Grace Therapeutics, Inc. (GRCE)

Purchase of 5,318 shares at $2.10 per share.

Reporting Person Opaleye Management Inc. · Transaction Code P

Traded Sep 23, 2026 · Disclosed Oct 1, 2026FILED +8 DAYS

Source: SEC Form 4 · 0001493152-26-045347 · filed 2026-10-01 · View filing →

SEC FORM 4
$20,519.10

Grace Therapeutics, Inc. (GRCE)

Purchase of 9,771 shares at $2.10 per share.

Reporting Person Opaleye Management Inc. · Transaction Code P

Traded Sep 21, 2026 · Disclosed Oct 1, 2026FILED +10 DAYS

Source: SEC Form 4 · 0001493152-26-045347 · filed 2026-10-01 · View filing →

SEC FORM 4CLUSTER · 2 INSIDERS
$245,895.66

Grace Therapeutics, Inc. (GRCE)

Purchase of 115,229 shares across 2 reporting persons.

Transaction Code P · Reporting Persons 2

  • Opaleye Management Inc.Purchase of 9,393 shares at $2.0972 per share.$19,699.00
  • Kohli Prashant, Chief Executive OfficerPurchase of 100,000 shares at $2.14 per share.$214,000.00
  • Opaleye Management Inc.Purchase of 5,836 shares at $2.0899 per share.$12,196.66

Surfaced by rule: 2 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001493152-26-042152 · filed 2026-09-10 · View filing →

Source: SEC Form 4 · 0001140361-26-036125 · filed 2026-09-10 · View filing →

SEC FORM 4
$24,206.16

Grace Therapeutics, Inc. (GRCE)

Purchase of 11,608 shares at $2.0853 per share.

Reporting Person Opaleye Management Inc. · Transaction Code P

Traded Aug 14, 2026 · Disclosed Aug 19, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001493152-26-039124 · filed 2026-08-19 · View filing →